GOSS - Financial Reports List - Gossamer Bio, Inc. - IntrinsicAlpha

Gossamer Bio, Inc. GOSS

Healthcare - Biotechnology - NASDAQ - US

$ 1.22

-2.54 %

$ 277 M

Market Cap

-5.23

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q1	8-K	2025-03-31	0.00%	12.62%	12.27%
Quarterly Report	Q4	8-K	2024-12-31	38.25%	31.40%	7.43%
Annual Report	FY	10-K	2024-12-31	0.00%	68.56%	67.39%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	23.01%	16.23%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	215.85%	212.50%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	14.72%	12.48%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	15.80%	28.20%
Annual Report	FY	10-K	2023-12-31	0.00%	25.15%	15.94%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	36.20%	27.72%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	28.05%	14.06%

1